Inactive Partial Small Business Set-Aside (FAR 19.5)

INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION The National Institutes of Hea... INTRODUCTION: THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION The National Institutes of Health (NIH), Clinical Center (CC), Office of Purchasing and Contracts (OPC) on behalf of the Critical Care Medicine Department, Clinical Center (CC) at the National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition to Protein Simple. NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE The intended procurement is classified under NAICS code 334516 with a Size Standard of 1000 # of Employees. REGULATORY AUTHORITY The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-95, MAY 6, 2020 .This acquisition is conducted under the procedures as prescribed in FAR subpart 13.106-1 Simplified Acquisition Procedures. STATUTORY AUTHORITY This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplifeid Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. GENERAL INFORMATION 1. Title- Protein Simple Milo System 2. Background Information: The Clinical Center at the National Institutes of Health (NIH) in Bethesda, Maryland, is the nation's largest hospital devoted entirely clinical research. It is a national resource that makes it possible to rapidly translate scientific observations and laboratory discoveries into new approaches for diagnosing, treating, and preventing disease. Approximately 1,500 studies are in progress at the NIH Clinical Center. Approximately, half of the studies are the first tests of new drugs or medical treatments in humans. The rest are natural history studies which include many rare diseases. These long-term studies lead to a better understanding of how diseases develop and result in improvements in prevention and treatment. 3. Purpose or Objective: Clinical Center has a clinical support team to address a procurement for the Milo Single Single-Cell Western System .Protein Cell is the only known vendor who is capable of providing the required equipment and system. this equipment. Milo, single-cell westerns system is an automated instrument that can measure protein expression in thousands of single cells in a single run, including cell surface marker and other markers that flow cannot process. Using this system, CCE will develop new protein detection protocol for CAR-T products and will be used for clinical lot release assay. 4. This new purchase will be used for follow assays: a. Measure proteins that don’t have good flow antibodies b. Simplify challenging flow assays (e.g., transcription factors) c. Measure protein isoform heterogeneity d. Analyze samples with low cell numbers (e.g., FACS-sorted cells or rare stem cells) e. Quantify transfection efficiency f. Reveal heterogeneity obscured by bulk Westerns g. Validate single-cell RNA data at the protein level 5. Delivery Date: after contract award CONTRACTOR REQUIREMENTS (SCOPE OF WORK) Vendor will provide the required deliverables of equipment to expand its current system capabilities and will seamlessly expand and integrate with existing system, components and equipment to allow the standardize its functionality of the system effectively. CONTRACTING WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION The intended sole source is the only known source to meet the technical needs of the Consultation services. The determination by the Government to award a contract without providing for full and open competition is based upon the market research conducted as prescribed in FAR Part 10-Market Research. CLOSING STATEMENT This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement. All responses must be received by June 29, 2020 at 10:00 PM Eastern time and must reference solicitation number 20-010744. Responses may be submitted electronically to Priscilla Abalos Contracting Specialist at Priscilla.abalos@nih.gov Fax responses will not be accepted. All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency."

Inactive Partial Small Business Set-Aside (FAR 19.5)

NIH- OPCSS-20-010744 The National Institutes of Health ("NIH"), Clinical Center is conducting a market survey/sources sought notice to determine whether there is a reasonable expectation of a responsi... NIH- OPCSS-20-010744 The National Institutes of Health ("NIH"), Clinical Center is conducting a market survey/sources sought notice to determine whether there is a reasonable expectation of a responsible/capable offeror to perform the work sought in the attached SOW. Accordingly, NIH is hoping that there exists a reasonable expectation of at least two responsible/capable offerors in order for NIH to compete the requirement. Additionally, NIH is attempting to ascertain if there exists a reasonable expectation of at least two responsible/capable small business offerors in order for NIH to compete the requirement as a small business set aside. Accordingly, NIH is seeking capability statements as the SOW attached from other-than-small businesses, small businesses, veteran-owned small businesses, service disabled veteran-owned small businesses, HUBZONE small businesses, small businesses under the 8(a) program, and/or businesses under the GSA Schedule which can perform on-schedule. THIS MARKET SURVEY/SOURCES SOUGHT ANNOUNCEMENT IS NOT A REQUEST FOR PROPOSALS, AND THE GOVERNMENT IS NOT COMMITTED TO AWARD A CONTRACT PURSUANT TO THIS ANNOUNCEMENT. CONSEQUENTLY, DO NOT SEND A PROPOSAL IN RESPONSE TO THIS NOTICE. THE APPROPRIATE RESPONSE IS A CAPABILITY STATEMENT. ALTHOUGH A RESPONDENT CAN RESPOND WITH WHATEVER INFORMATION THE RESPONDENT SEES FIT, THE IDEAL CAPABILITY STATEMENT SPECIFICALLY ADDRESSES THE REQUIREMENTS IN THE SOW AND THE REQUESTS FOR INFORMATION BELOW, AND IS NOT A GENERIC SALES BROCHURE OR MARKETING HANDOUT. FURTHER, THE GOVERNMENT REQUESTS, BUT DOES NOT MANDATE, THAT THE CAPABILITY STATEMENT IS LIMITED TO NO MORE THAN TEN PAGES. ANY PROPRIETARY INFORMATION IN THE SUBMITTED CAPABILITY STATEMENT SHOULD BE CLEARLY MARKED AS SUCH. The information obtained from this market research is for Government planning purposes only, and will assist the Government in planning its acquisition strategy. This is strictly market research, and the Government is not opening a question and answer period concerning this market research. Further, the Government will not pay for any costs incurred in the preparation of information in response to this market survey. In addition to addressing the requirements in the attached SOW, the Government requests that your capability statement address the following requests for information, if relevant. 1) Please provide the full company/entity name, address including points of contact (phone number and e-mail address), DUNS numbers, and type/size of the company/entity by NAICS code. 2) If your company/entity is a dealer or service-provider, and not a manufacturer of the end items/products contemplated by the SOW, please identify your company as such and identify the end item/product manufacturers that you would be obtaining goods from in order to perform the contract, and where the manufacturers are geographically located. 3) According to the small business limitations on subcontracting standard provided by the amended Small Business Act at 15 U.S.C. § 657s, the requirement for a small business supplier is that the small business prime contractor "may not expend on subcontractors more than 50 percent of the amount, less the cost of materials, paid to the concern under the contract . . . ." 15 U.S.C. § 657s(a)(2). However, "[c]ontract amounts expended by a covered small business concern on a subcontractor that is a similarly situated entity [(i.e., another small/small disadvantaged business of the same type)] shall not be considered subcontracted for purposes of determining whether the covered small business concern has violated [limitations on subcontracting.]" 15 U.S.C. § 657s(b). If you are a small business, please address your ability to adhere to limitations on subcontracting at 15 U.S.C. § 657s. To ascertain if you are a small business, use the size standard provided by NAICS Code 811219 (other electronic and precision equipment), with a size standard of no more than $20.5 million. As part of this, if you are a small business that is a dealer/service-provider and not a manufacturer, please so state, and address whether you meet the following requirements from 13 C.F.R. § 121.406(b). Specifically, your company/entity: (1) Does not exceed 500 employees (notice that the employee standard under the non-manufacturer rule is restrictive by employees, and NAICS Code 334516is restrictive by dollars); (2) Is primarily engaged in the retail or wholesale trade and normally sells the type of item being supplied; (3) Takes ownership or possession of the item(s) with its personnel, equipment or facilities in a manner consistent with industry practice; and (4) Will supply the end item of a small business manufacturer, processor, or producer made in the United States. NIH must receive written capability statements no later than June 19, 2020 9:00 a.m. Eastern Time. E-mail the written capability statement to Telephone inquiries will not be accepted or acknowledged, and no feedback or evaluations will be provided to companies regarding their submissions. Capability Statement - Any potential offeror must demonstrate the following: The government will evaluate market information to ascertain potential market capacity, experience and capability in the following areas : 1) Address your ability, experience and capacity to perform service maintenance of eight Scientific Freezers. 3) Provide the following business information: a. DUNS b. Company Name c. Company Address (including point of contact, phone number and email address) e. Type/Size of company, NAICS code as validated via the Central Contractor Registration (CCR) The synopsis is for information and planning purposes and is not to be construed as a commitment by the Government. This is not a solicitation announcement for proposals and no contract will be awarded from this announcement. No reimbursement will be made for any costs associated with providing information in response to this announcement and any follow-up information requests. Respondents will not be notified of the results of the evaluation. All information submitted in response to this announcement must arrive on or before the closing date. Responses must be submitted not later than JUNE 20,2020 via e-mail to the point of contact listed below. Attn : Priscilla Abalos, Contract Specialist 6707 Democracy Blvd Suite 106, Bethesda MD 20892 E-mail: priscilla.abalos@nih.gov